Literature DB >> 24760309

Clinical outcomes and quality of life in patients with nasal polyposis after functional endoscopic sinus surgery.

Vojko Djukic1, Zoran Dudvarski, Nenad Arsovic, Milovan Dimitrijevic, Ljiljana Janosevic.   

Abstract

The majority of studies have shown that the use of functional endoscopic sinus surgery (FESS) leads to symptomatic improvement in 73-98.4 % of patients with chronic rhinosinusitis and nasal polyposis (NP). The aim of the study is to evaluate clinical outcomes and quality of life (QoL) in patients with NP after FESS. The prospective study included 85 consecutive adult patients (≥18 years) with NP who were operated on using FESS after failure of the medicamentous treatment and in certain cases of surgical treatment. QoL was assessed by Short Form-36 Health Survey (SF-36) questionnaire, and the symptom intensity was presented using visual analogue scale (VAS). The objective finding was presented as endoscopic and computerized tomography (CT) score. The intensity of each symptom, the values of symptom scores (major, minor and total), the values of dimension scales and summary scales of the QoL, as well as the values of endoscopic score through three periods of time (pre-surgery, 6 and 12 months after the surgery) were analyzed. Following the FESS, mean intensity values of all individual symptoms and symptom scores were significantly lower and the values of all dimension scales and summary scales of QoL were significantly higher (p < 0.05). There was no statistically significant difference in symptom intensity and QoL after 6 and 12 months of surgical treatment (p > 0.05). Endoscopic score was on average significantly lower after 6 and 12 months of FESS (p < 0.05), but the mean score value after 12 months of operation was significantly higher in relation to that after 6 months of surgery (p < 0.05). Nevertheless, the recurrence of NP was observed in 28 patients (32.9 %) in the follow-up period. In conclusion, FESS in NP patients results in significant improvement of symptom intensity, QoL and endoscopic score. While the intensity of symptoms and QoL showed a tendency to maintain between 6 and 12 months after surgery, endoscopic score showed a tendency of exacerbation in the same period.

Entities:  

Mesh:

Year:  2014        PMID: 24760309     DOI: 10.1007/s00405-014-3054-y

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  26 in total

1.  Kinetics of olfactory function following endonasal sinus surgery for nasal polyposis.

Authors:  Philipp A Federspil; Ruth Wilhelm-Schwenk; Jannis Constantinidis
Journal:  Rhinology       Date:  2008-09       Impact factor: 3.681

2.  Functional endoscopic sinus surgery: evaluation, surgery, and follow-up of 250 patients.

Authors:  H L Levine
Journal:  Laryngoscope       Date:  1990-01       Impact factor: 3.325

3.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

4.  [Sinus-nasal polyposis: one-year outcome after endoscopic sinus surgery followed by topical corticosteroid therapy in 72 patients].

Authors:  P Rombaux; C De Toeuf; M Hamoir; P Eloy; B Bertrand
Journal:  Ann Otolaryngol Chir Cervicofac       Date:  2001-10

5.  Functional endoscopic sinus surgery in chronic sinusitis--a series of 237 consecutively operated patients.

Authors:  J Jakobsen; F Svendstrup
Journal:  Acta Otolaryngol Suppl       Date:  2000

6.  Clinical and symptom criteria for the accurate diagnosis of chronic rhinosinusitis.

Authors:  Neil Bhattacharyya
Journal:  Laryngoscope       Date:  2006-07       Impact factor: 3.325

7.  The impact of asthma and aspirin sensitivity on quality of life of patients with nasal polyposis.

Authors:  Isam Alobid; Pedro Benítez; Manuel Bernal-Sprekelsen; José María Guilemany; Cesar Picado; Joaquim Mullol
Journal:  Qual Life Res       Date:  2005-04       Impact factor: 4.147

8.  Impact of aspirin intolerance on outcomes of sinus surgery.

Authors:  Jamie L Robinson; Susan Griest; Kenneth E James; Timothy L Smith
Journal:  Laryngoscope       Date:  2007-05       Impact factor: 3.325

9.  The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs.

Authors:  C A McHorney; J E Ware; A E Raczek
Journal:  Med Care       Date:  1993-03       Impact factor: 2.983

10.  Recurrence rates after endoscopic sinus surgery for massive sinus polyposis.

Authors:  Rhoda Wynn; Gady Har-El
Journal:  Laryngoscope       Date:  2004-05       Impact factor: 3.325

View more
  6 in total

1.  Quality of life before and after sinonasal surgery: a population-based matched cohort study.

Authors:  Antti I Alakärppä; Timo J Koskenkorva; Petri T Koivunen; Olli-Pekka Alho
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-23       Impact factor: 2.503

2.  Endoscopic sinus surgery outcomes in CRS: quality of life and correlations with NOSE scale in a prospective cohort study.

Authors:  Athanasios Saratziotis; Enzo Emanuelli; Claudia Zanotti; George Mireas; Pavlos Pavlidis; Maria Ferfeli; Jiannis Hajiioannou
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-09-08       Impact factor: 2.503

3.  Review article: outcomes in endoscopic sinus surgery.

Authors:  Edward Noon; Claire Hopkins
Journal:  BMC Ear Nose Throat Disord       Date:  2016-08-05

4.  General health, vitality, and social function after sinus surgery in chronic rhinosinusitis.

Authors:  Ann Helen Nilsen; Anne-Sofie Helvik; Wenche Moe Thorstensen; Øyvind Salvesen; Vegard Bugten
Journal:  Laryngoscope Investig Otolaryngol       Date:  2019-08-12

5.  Prospective, randomized, controlled, open-label study to compare efficacy of a mineral-rich solution vs normal saline after complete ethmoidectomy.

Authors:  Ludovic de Gabory; Virginie Escabasse; Philippe Boudard; Guillaume de Bonnecaze; Cécile Rumeau; Roger Jankowski; Christian Debry; Sylvain Morinière; Bertrand Merino; Geoffrey Mortuaire; Olivier Malard; Laurence Bordenave
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-12-08       Impact factor: 2.503

6.  B Cell-Activating Factor Promotes B Cell Survival in Ectopic Lymphoid Tissues in Nasal Polyps.

Authors:  Zhe-Zheng Wang; Jia Song; Hai Wang; Jing-Xian Li; Qiao Xiao; Ze Yu; Jin-Xin Liu; Zheng Liu
Journal:  Front Immunol       Date:  2021-01-20       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.